Neuralink is a dominant force in the BCI space, but the arrival of a new, well-capitalised startup in Merge Labs may change the conversation.

Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to Elon Musk in the high-stakes brain-computer interface market. Altman is co-founding a new venture,

Merge Labs venture comes after OpenAI boss Sam Altman said the race to embed AI in humans is ‘going to get a lot weirder’

Sam Altman is preparing to co-found a new company funded by OpenAI that will go up against Elon Musk's Neuralink, The Financial Post reported. The startup, called Merge Labs, will use AI for its brain-computer interface and compete directly with Neuralink,

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

The rollout was even messy enough to spill into betting markets. One 27-year-old day trader, Foster McCoy, pocketed $10,000 in just a few hours by wagering that Google’s Gemini would beat GPT-5 in a popularity contest.

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is reportedly valued at $850 million. Merge Labs is expected to develop advanced neural interface systems that may soon allow humans to interact with machines based on their thoughts,